Advertisement

Bleeding-Avoidance Strategies and Outcomes in Patients ≥80 Years of Age With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the NCDR CathPCI Registry)

      The purpose of our study was to evaluate the use of bleeding-avoidance strategies (BAS) and risk-adjusted bleeding over time in patients ≥80 years of age undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction. We analyzed data from the CathPCI Registry from July 1, 2006 through June 30, 2009. Patients were included if they were ≥80 years old, presented with ST-segment elevation myocardial infarction, and underwent primary PCI. We evaluated trends in use of BAS (direct thrombin inhibitors, vascular closure devices, and radial access) and risk-adjusted bleeding over time. Of 10,469 patients ≥80 years old undergoing primary PCI, 1,002, (9.6%) developed a bleeding complication. Use of direct thrombin inhibitors and vascular closure devices increased over time (12.8% to 24.9% and 29.2% to 32.7%, p <0.01 and <0.05 for trends, respectively). Radial access was extremely uncommon (<1%) and did not change over the course of the study. In multivariable analyses, use of BAS was associated with lower bleeding. However, over the course of the study period, overall risk-adjusted bleeding did not decrease significantly (9.9% to 9.4%, p = 0.14 for trend). In conclusion, patients ≥80 years old undergoing primary PCI are at high risk of bleeding, and despite significant increases in use of BAS, the overall rate of bleeding complications remains high.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Avezum A.
        • Makdisse M.
        • Spencer F.
        • Gore J.M.
        • Fox K.A.
        • Montalescot G.
        • Eagle K.A.
        • White K.
        • Mehta R.H.
        • Knobel E.
        • Collet J.P.
        • GRACE Investigators
        Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).
        Am Heart J. 2005; 149: 67-73
        • Claessen B.E.P.M.
        • Kikkert W.J.
        • Engstrom A.E.
        • Hoebers L.P.C.
        • Damman P.
        • Vis M.M.
        • Koch K.T.
        • Baan J.
        • Meuwissen M.
        • van der Schaaf J.R.
        • de Winter R.J.
        • Tijssen J.G.P.
        • Piek J.J.
        • Henriques J.P.S.
        Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: trends and outcomes.
        Heart. 2010; 96: 843-847
        • Merchant F.M.
        • Weiner R.B.
        • Rao S.R.
        • Lawrence R.
        • Healy J.L.
        • Pomerantsev E.
        • Rosenfield K.
        • Jang I.K.
        In-hospital outcomes of emergent and elective percutaneous coronary intervention in octogenarians.
        Coron Artery Dis. 2009; 20: 118-123
        • Moscucci M.
        • Fox K.A.
        • Cannon C.P.
        • Klein W.
        • López-Sendón J.
        • Montalescot G.
        • White K.
        • Goldberg R.J.
        Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).
        Eur Heart J. 2003; 24: 1815-1823
        • Kinnaird T.
        • Anderson R.
        • Hill J.
        • Thomas M.
        Bleeding during percutaneous intervention: tailoring the approach to minimise risk.
        Heart. 2009; 95: 15-19
        • Lemesle G.
        • De Labriolle A.
        • Bonello L.
        • Syed A.
        • Collins S.
        • Maluenda G.
        • Torguson R.
        • Kaneshige K.
        • Xue Z.
        • Suddath W.O.
        • Satler L.F.
        • Kent K.M.
        • Lindsay J.
        • Pichard A.D.
        • Waksman R.
        Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
        Catheter Cardiovasc Interv. 2009; 74: 428-435
        • Brindis R.G.
        • Fitzgerald S.
        • Anderson H.V.
        • Shaw R.E.
        • Weintraub W.S.
        • Williams J.F.
        The American College of Cardiology–National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository.
        J Am Coll Cardiol. 2001; 37: 2240-2245
        • National Cardiovascular Data Registry
        (Accessed January 3, 2011)
        • Rathore S.S.
        • Curtis J.P.
        • Chen J.
        • Wang Y.
        • Nallamothu B.K.
        • Epstein A.J.
        • Krumholz H.M.
        Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study.
        Bmj. 2009; 338: b1807
        • Stone G.W.
        • McLaurin B.T.
        • Cox D.A.
        • Bertrand M.E.
        • Lincoff A.M.
        • Moses J.W.
        • White H.D.
        • Pocock S.J.
        • Ware J.H.
        • Feit F.
        • Colombo A.
        • Aylward P.E.
        • Cequier A.R.
        • Darius H.
        • Desmet W.
        • Ebrahimi R.
        • Hamon M.
        • Rasmussen L.H.
        • Rupprecht H.J.
        • Hoekstra J.
        • Mehran R.
        • Ohman E.M.
        • ACUITY Investigators
        Bivalirudin for patients with acute coronary syndromes.
        N Engl J Med. 2006; 355: 2203-2216
        • Marso S.P.
        • Amin A.P.
        • House J.A.
        • Kennedy K.F.
        • Spertus J.A.
        • Rao S.V.
        • Cohen D.J.
        • Messenger J.C.
        • Rumsfeld J.S.
        • National Cardiovascular Data Registry
        Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.
        Jama. 2010; 303: 2156-2164
        • Rao S.V.
        • Ou F.
        • Wang T.Y.
        • Roe M.T.
        • Brindis R.
        • Rumsfeld J.S.
        • Peterson E.D.
        Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry.
        JACC Cardiovasc Interv. 2008; 1: 379-386
        • Jolly S.S.
        • Yusuf S.
        • Cairns J.
        • Niemelä K.
        • Xavier D.
        • Widimsky P.
        • Budaj A.
        • Niemelä M.
        • Valentin V.
        • Lewis B.S.
        • Avezum A.
        • Steg P.G.
        • Rao S.V.
        • Gao P.
        • Afzal R.
        • Joyner C.D.
        • Chrolavicius S.
        • Mehta S.R.
        • RIVAL Trial Group
        Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.
        Lancet. 2011; 377: 1409-1420
        • Mehta S.K.
        • Frutkin A.D.
        • Lindsey J.B.
        • House J.A.
        • Spertus J.A.
        • Rao S.V.
        • Ou F.S.
        • Roe M.T.
        • Peterson E.D.
        • Marso S.P.
        • National Cardiovascular Data Registry
        Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry.
        Circ Cardiovasc Interv. 2009; 2: 222-229
        • Lee D.S.
        • Tu J.V.
        • Juurlink D.N.
        • Alter D.A.
        • Ko D.T.
        • Austin P.C.
        • Chong A.
        • Stukel T.A.
        • Levy D.
        • Laupacis A.
        Risk-treatment mismatch in the pharmacotherapy of heart failure.
        Jama. 2005; 294: 1240-1247
        • Mehran R.
        • Pocock S.J.
        • Stone G.W.
        • Clayton T.C.
        • Dangas G.D.
        • Feit F.
        • Manoukian S.V.
        • Nikolsky E.
        • Lansky A.J.
        • Kirtane A.
        • White H.D.
        • Colombo A.
        • Ware J.H.
        • Moses J.W.
        • Ohman E.M.
        Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.
        Eur Heart J. 2009; 30: 1457-1466
        • Kinnaird T.D.
        • Stabile E.
        • Mintz G.S.
        • Lee C.W.
        • Canos D.A.
        • Gevorkian N.
        • Pinnow E.E.
        • Kent K.M.
        • Pichard A.D.
        • Satler L.F.
        • Weissman N.J.
        • Lindsay J.
        • Fuchs S.
        Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.
        Am J Cardiol. 2003; 92: 930-935
        • Wang T.Y.
        • Gutierrez A.
        • Peterson E.D.
        Percutaneous coronary intervention in the elderly.
        Nat Rev Cardiol. 2011; 8: 79-90
        • Alexander K.P.
        • Chen A.Y.
        • Roe M.T.
        • Newby L.K.
        • Gibson C.M.
        • Allen-LaPointe N.M.
        • Pollack C.
        • Gibler W.B.
        • Ohman E.M.
        • Peterson E.D.
        • CRUSADE Investigators
        Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute coronary syndromes.
        Jama. 2005; 294: 3108-3116
        • Stone G.W.
        • Witzenbichler B.
        • Guagliumi G.
        • Peruga J.Z.
        • Brodie B.R.
        • Dudek D.
        • Kornowski R.
        • Hartmann F.
        • Gersh B.J.
        • Pocock S.J.
        • Dangas G.
        • Wong S.C.
        • Kirtane A.J.
        • Parise H.
        • Mehran R.
        • HORIZONS-AMI Trial Investigators
        Bivalirudin during primary PCI in acute myocardial infarction.
        N Engl J Med. 2008; 358: 2218-2230
        • Lopes R.D.
        • Alexander K.P.
        • Manoukian S.V.
        • Bertrand M.E.
        • Feit F.
        • White H.D.
        • Pollack Jr, C.V.
        • Hoekstra J.
        • Gersh B.J.
        • Stone G.W.
        • Ohman E.M.
        Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
        J Am Coll Cardiol. 2009; 53: 1021-1030
        • Patel M.R.
        • Jneid H.
        • Derdeyn C.P.
        • Klein L.W.
        • Levine G.N.
        • Lookstein R.A.
        • White C.J.
        • Yeghiazarians Y.
        • Rosenfield K.
        • American Heart Association Diagnostic and Interventional Cardiac Catheterization Committee of the Council on Clinical Cardiology, Council on Cardiovascular Radiology and Intervention, Council on Peripheral Vascular Disease, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council
        Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association.
        Circulation. 2010; 122: 1882-1893
        • Koreny M.
        • Riedmüller E.
        • Nikfardjam M.
        • Siostrzonek P.
        • Müllner M.
        Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis.
        Jama. 2004; 291: 350-357
        • Dauerman H.L.
        • Rao S.V.
        • Resnic F.S.
        • Applegate R.J.
        Bleeding avoidance strategies.
        J Am Coll Cardiol. 2011; 58: 1-10
        • Vaitkus P.T.
        A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention.
        J Invasive Cardiol. 2004; 16: 243-246
        • Arora N.
        • Matheny M.E.
        • Sepke C.
        • Resnic F.S.
        A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices.
        Am Heart J. 2007; 153: 606-611
        • Bangalore S.
        • Arora N.
        • Resnic F.S.
        Vascular closure device failure: frequency and implications: a propensity-matched analysis.
        Circ Cardiovasc Interv. 2009; 2: 549-556
        • Dauerman H.L.
        • Applegate R.J.
        • Cohen D.J.
        Vascular closure devices: the second decade.
        J Am Coll Cardiol. 2007; 50: 1617-1626
        • Caputo R.P.
        • Tremmel J.A.
        • Rao S.
        • Gilchrist I.C.
        • Pyne C.
        • Pancholy S.
        • Frasier D.
        • Gulati R.
        • Skelding K.
        • Bertrand O.
        • Patel T.
        Transradial arterial access for coronary and peripheral procedures: executive summary by the transradial committee of the SCAI.
        Catheter Cardiovasc Interv. 2011; 78: 823-829